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Abstract
Background
Health authorities in the United States and Europe reported an increasing number of travel-
associated episodes of sexual transmission of Zika virus (ZIKV) following the 2015–2017
ZIKV outbreak. This, and other scientific evidence, suggests that ZIKV is sexually transmis-
sible in addition to having its primary mosquito-borne route. The objective of this systematic
review and evidence synthesis was to clarify the epidemiology of sexually transmitted ZIKV.
Methods and findings
We performed a living (i.e., continually updated) systematic review of evidence published up
to 15 April 2018 about sexual transmission of ZIKV and other arthropod-borne flaviviruses in
humans and other animals. We defined 7 key elements of ZIKV sexual transmission for
which we extracted data: (1) rectal and vaginal susceptibility to infection, (2) incubation
period following sexual transmission, (3) serial interval between the onset of symptoms in a
primary and secondary infected individuals, (4) duration of infectiousness, (5) reproduction
number, (6) probability of transmission per sex act, and (7) transmission rate. We identified
1,227 unique publications and included 128, of which 77 presented data on humans and 51
presented data on animals. Laboratory experiments confirm that rectal and vaginal muco-
sae are susceptible to infection with ZIKV and that the testis serves as a reservoir for the
virus in animal models. Sexual transmission was reported in 36 human couples: 34/36 of
these involved male-to-female sexual transmission. The median serial symptom onset inter-
val in 15 couples was 12 days (interquartile range: 10–14.5); the maximum was 44 days.
We found evidence from 2 prospective cohorts that ZIKV RNA is present in human semen
with a median duration of 34 days (95% CI: 28–41 days) and 35 days (no CI given) (low cer-
tainty of evidence, according to GRADE). Aggregated data about detection of ZIKV RNA
from 37 case reports and case series indicate a median duration of detection of ZIKV of 40
days (95% CI: 30–49 days) and maximum duration of 370 days in semen. In human vaginal
fluid, median duration was 14 days (95% CI: 7–20 days) and maximum duration was 37
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days (very low certainty). Infectious virus in human semen was detected for a median dura-
tion of 12 days (95% CI: 1–21 days) and maximum of 69 days. Modelling studies indicate
that the reproduction number is below 1 (very low certainty). Evidence was lacking to esti-
mate the incubation period or the transmission rate. Evidence on sexual transmission of
other flaviviruses was scarce. The certainty of the evidence is limited because of uncon-
trolled residual bias.
Conclusions
The living systematic review and sexual transmission framework allowed us to assess evi-
dence about the risk of sexual transmission of ZIKV. ZIKV is more likely transmitted from
men to women than from women to men. For other flaviviruses, evidence of sexual trans-
missibility is still absent. Taking into account all available data about the duration of detec-
tion of ZIKV in culture and from the serial interval, our findings suggest that the infectious
period for sexual transmission of ZIKV is shorter than estimates from the earliest post-out-
break studies, which were based on reverse transcription PCR alone.
Author summary
Why was this study done?
• Sexual transmission of Zika virus (ZIKV) is now documented, but the risks of transmis-
sion are not well understood.
• It is not known whether other flaviviruses can be transmitted through sexual
intercourse.
What did the researchers do and find?
• We developed a sexual transmission framework for ZIKV infection that identified 7 key
elements related to ZIKV sexual transmission, and we conducted a living systematic
review through 15 April 2018 of available evidence about each element.
• We found that, where documented, sexual transmission of ZIKV is much more com-
mon from men to women than from women to men. For sexual transmission of ZIKV,
the median serial interval—the time between onset of symptoms in 2 sexual partners—
is 12 days.
• The median duration of ZIKV RNA persistence in semen is longer (34 days) than in the
female genital tract (12 days). ZIKV can be detected for longer periods using reverse
transcription polymerase chain reaction compared to viral culture.
• We found no evidence of sexual transmission for any other arthropod-borne
flaviviruses.
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What do these findings mean?
• Studies about the duration of detection of ZIKV in bodily fluids and the serial interval
suggest that the period ZIKV can be transmitted through sexual contact might be
shorter than was estimated from the earliest studies in 2016.
Introduction
Zika virus (ZIKV) can be transmitted between humans through sexual contact, although it is
most commonly transmitted by infected Aedes spp. mosquitoes [1,2]. Sexual transmission of
ZIKV has important implications for public health, for people living in endemic regions, and
for sexual partners of travellers returning to non-endemic regions from endemic regions
because ZIKV infection during pregnancy can cause congenital infection of the foetus and
because ZIKV infection can trigger the immune-mediated neurological condition Guillain-
Barre´ syndrome [3,4]. ZIKV is an RNA flavivirus. Flaviviruses are a genus of viruses from the
Flaviviridae family, of which the majority are transmitted to vertebrates by infected mosquito
or tick vectors [5].
Scientists working in Senegal in 2008 were the first to report presumed sexual transmission
of ZIKV in a case report that documented their own symptoms and serological findings [6].
One scientist developed symptoms after returning to the US, and his wife, who had not trav-
elled outside the US, became unwell 4 days later. The large ZIKV outbreak (2015–2017) in the
Americas resulted in additional reports of travel-associated ZIKV sexual transmission in the
US and Europe, which Moreira and colleagues synthesised descriptively in a systematic review
of the literature up to December 2016 [7]. In vivo and in vitro experimental studies have pro-
vided evidence of the biological plausibility of this route of infection [8].
While possible sexual transmission has been established, there are many unanswered ques-
tions about the transmissibility of ZIKV through sexual intercourse. For mosquito-borne
ZIKV infection, the incubation period and duration of viral shedding in serum have been esti-
mated, allowing implications for blood donation to be assessed [9]. Additional information
about parameters related to person-to-person transmission of ZIKV has not been systemati-
cally collated or quantified, although several narrative reviews have been published [10,11].
Evidence about sexual transmission of other arthropod-borne flaviviruses in humans, includ-
ing West Nile virus (WNV), yellow fever virus (YFV), Japanese encephalitis virus (JEV), and
dengue virus (DENV) [12], has not been synthesised, but WNV and YFV have been detected
in human semen [13,14]. The primary objective of this review was to systematically review evi-
dence about defined aspects of the sexual transmission of ZIKV. Secondary objectives were to
systematically review evidence about the sexual transmissibility of other arthropod-borne flavi-
viruses and to establish these reviews using a living systematic review approach [15].
Methods
Sexual transmission framework
In March 2017, we developed a sexual transmission framework for ZIKV [16,17], based on
standard concepts about person-to-person transmission of infection [18]. The framework
includes key elements in the course of an infection in an individual and transmission to a sex-
ual partner, some of which can be measured and others that can only be determined indirectly
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or through modelling. Fig 1 shows these elements and the relationships between them: (1) sus-
ceptibility to infection, (2) incubation period after sexual transmission, (3) serial interval, (4)
duration of infectiousness, (5) reproduction number, (6) probability of transmission per sex
act, and (7) transmission rate. The framework does not include transmission from and to mos-
quitoes, which would be needed to estimate the proportion of all ZIKV infections due to sexual
transmission. The sexual transmission framework defined the outcomes and informed the
structure of the review.
Living systematic review
We performed this review as a living systematic review [15] because research into many
aspects of ZIKV is a new and fast-moving field. Several studies are ongoing [19] and have pub-
lished interim results [20], and updated results could affect public health decisions. The
Fig 1. A schematic representation of the sexual transmission of Zika virus and 7 key elements. Numbered circles show the 7 key elements. Dark
blue circles are elements for which evidence is based on empirical research. Light blue circles denote elements derived from mathematical modelling
studies and in vivo studies. (A) Transmission between 2 individuals. The horizontal arrows show the time course of the disease for the primary
infected individual (I), who is infected, and the secondary individual (S), who starts as susceptible (element 1). The vertical red arrow represents a Zika
virus transmission event, after which there is an incubation period (element 2) before symptoms develop. Element 3 is the serial interval, i.e., the
period between the start of symptoms in the primary and the secondary individual. Element 4 is the duration of infectiousness. After the infection,
individuals can become immune. (B) Relation between different elements at population level. The reproduction number (element 5) is the result of the
contact rate, the probability of transmission per act (element 6), and the duration of infectiousness (4). The transmission rate (element 7) can be
estimated using the reproduction number (5) and the serial interval (3). Adapted with permission from World Health Organization [16].
https://doi.org/10.1371/journal.pmed.1002611.g001
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protocol for this review was registered on 19 May 2017 in the database PROSPERO
(CRD42017060338) [21]. We summarise the details that make the review a living systematic
review in S1 Text. Future updates will be reported quarterly online (http://zika.ispm.unibe.ch/stf/)
and in the online comments section of this publication. Reporting is in accordance with the Pre-
ferred Reporting Items for Systematic Reviews and Meta-Analyses (S1 PRISMA Checklist).
Search strategy
The search includes the electronic databases PubMed, Embase, bioRxiv, arXiv, PeerJ, and
LILACS and online repositories from the US Centers for Disease Control and Prevention, the
European Centre for Disease Prevention and Control, the Pan American Health Organization,
and the World Health Organization from the earliest date of each database and without lan-
guage restrictions. The searches include Medical Subject Headings (MeSH) terms and key-
words for ZIKV and flaviviruses together with terms and keywords for viral persistence and
sexual transmission (S1 Text). An automated search is run every day, with results deduplicated
and imported into REDCap (Research Electronic Data Capture). We checked reference lists of
included studies to identify additional relevant studies. For this report, we identified studies
published before and up to 15 April 2018.
Eligibility criteria
We included observational studies, in vitro and in vivo studies, and mathematical modelling
studies that directly addressed any of the elements of the sexual transmission framework in
either humans or animals for ZIKV or another arthropod-borne flavivirus. We included obser-
vational studies that reported 1 or more cases of sexual transmission, 1 or more measurements
of presence of virus in bodily fluids, or both. As bodily fluids we included semen, cervical and
vaginal secretions, and saliva; diagnostic methods included reverse transcription polymerase
chain reaction (RT-PCR) and viral culture. We did not include reviews, editorials, or commen-
taries that did not report original data. Table 1 provides an overview of the eligibility criteria
Table 1. Eligibility criteria for each outcome.
Outcomes Eligible study designs Detailed eligibility criteria
Primary outcomes
Element 2. Incubation period
following sexual transmission
Observational epidemiological studies in humans (case
reports, case series, cohort studies, case–control studies,
surveillance/outbreak reports)
Observational studies that report incubation period due to sexual
transmission
Element 3. Serial interval Observational epidemiological studies in humans Observational studies that describe sexual transmission in humans
where serial interval (time between onset of symptoms between
sexual partners) is reported
Element 4. Duration of
infectiousness
Observational epidemiological studies in humans Observational studies that report duration of detection of virus in
semen, cervical and vaginal secretions, and saliva; diagnostic methods
included reverse transcription PCR and viral culture
Secondary outcomes
Element 1. Susceptibility Basic research studies (in vivo/in vitro studies) In vivo/in vitro studies that report on the presence of virus in the
female genital tract, the male genital tract, or saliva, or on sexual
transmission of virus
Element 5. Reproduction
number due to sexual
transmission
Mathematical modelling studies Modelling studies that report on the elements of interest
Element 6. Probability of
transmission per sex act
Mathematical modelling studies Modelling studies that report on the elements of interest
Element 7. Transmission rate Mathematical modelling studies Modelling studies that report on the elements of interest
https://doi.org/10.1371/journal.pmed.1002611.t001
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for each outcome. Primary outcomes can be directly estimated from observational studies, and
secondary outcomes are calculated or inferred from indirect evidence.
Study selection and data extraction
One reviewer screened titles and abstracts of retrieved papers. If retained in the first step, the same
reviewer screened the full text of the paper. One reviewer extracted data into piloted extraction
forms in REDCap [22]. A second reviewer verified exclusion decisions and data entry.
Synthesis of the evidence
We provide descriptive summaries of findings about the elements of the ZIKV sexual trans-
mission framework for basic research studies (element 1), observational epidemiological stud-
ies (elements 2–4), and mathematical modelling studies (elements 5–7). In addition, we used
data from included studies to calculate estimates for the serial interval (i.e., the period between
the start of symptoms in the primary and the secondary individual) and the duration of the
detection of ZIKV. We report the median serial interval and its interquartile range. To esti-
mate the duration of detection of ZIKV positivity, we conducted interval-censored survival
analysis and fitted Weibull distributions using the “straweib” package [23,24] in R (version
3.4.1), based on previous studies [20,23,24]. We assumed that all infected patients were
RT-PCR or viral culture positive at symptom onset. We report median estimated durations
and corresponding 95% confidence intervals. Additional information about the methods is
provided in S2 Text. For other flaviviruses, we summarise findings from all study types
descriptively.
Certainty assessment of the evidence
We assessed the methodology of included studies using specific checklists for each study type.
For observational studies, we used the National Institutes of Health (NIH) Quality Assessment
Tool for Case Series Studies [25] and UK National Institute for Health and Care Excellence
(NICE) checklists for case–control studies and cohort studies [26]. For in vivo studies we used
the SYstematic Review Centre for Laboratory animal Experimentation (SYRCLE) risk of bias
tool for animal studies [27], and for mathematical modelling studies, the International Society
for Pharmacoeconomics and Outcomes Research (ISPOR) Questionnaire to Assess Relevance
and Credibility of Modelling Studies [28]. We performed the assessment by a consensus-driven
approach among multiple reviewers. We appraised the certainty of the key elements according
to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) tool
[29–31] (S3 Table). In accordance with GRADE, assessments of the overall certainty of evidence
from observational studies started at low certainty. We downgraded the level of certainty for
small sample size and evidence from case reports or case series. We assessed outcomes of math-
ematical modelling studies as high, medium, low, or very low certainty.
Results
We identified 1,227 unique citations and excluded 901 by title and abstract screening (Fig 2).
Of the remaining 326 potentially eligible citations with relevant abstracts, 128 publications
were eligible for inclusion. Table 2 summarises characteristics of the included studies.
Basic research studies
We included 41 in vivo and in vitro studies of ZIKV [32–69] (Table 2). Of these 41 studies, 6
were in vitro studies and 35 were studies in in vivo animal models: 12 in nonhuman primates
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(NHPs) such as cynomolgus macaques (Macaca fascicularis), rhesus macaques (M. mulatta),
and common marmosets (Callithrix jacchus) and 23 in mice. In 1 study, both guinea pigs and
NHPs were used [64]. These studies provide insight into the underlying biological mechanisms
of susceptibility to ZIKV infection through sexual transmission and substantiate the biological
plausibility of this transmission route.
Susceptibility (element 1)
In mouse and NHP models, the vaginal and rectal mucosae were shown to be susceptible to
infection with ZIKV [36,40,47,49,51,59]. When ZIKV-infected male mice were mated with
uninfected female mice, the female mice became infected [47,53,69]. Female-to-male transmis-
sion of ZIKV in mice was unsuccessful [47]. In rhesus macaques, systemic infection through
Fig 2. Flow diagram of reviewed studies. Numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each
stage.
https://doi.org/10.1371/journal.pmed.1002611.g002
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oropharyngeal mucosal inoculation with ZIKV was only successful after inoculation with a
very high dose of virus, suggesting a very low risk of oral mucosal transmission [54]. Four rhe-
sus macaques became viraemic after intranasal or intragastric inoculation with ZIKV [64]. In
guinea pigs, direct transmission between animals infected subcutaneously with ZIKV and co-
housed uninfected animals was seen [64].
Human prostate cells, testicular cells, and mature spermatozoa are susceptible in vitro to
ZIKV infection [35,60–62]. Human Sertoli cells can support high levels of ZIKV replication
and persistence [70]. In multiple mouse models, using different strains of ZIKV, the testes
seem to be a preferred site for viral replication, able to sustain high viral loads for a longer
duration than other organs [32,34,35,43,47,49,51,58,63]. In some of these models, ZIKV
caused inflammation of the testes [35,39,41,47,49], reduced testicular size, and decreased levels
of testosterone [49,56,68,71]. The testes of experimentally infected NHPs harboured high levels
of ZIKV [37,38]. High titres of ZIKV RNA were detectable in semen until day 28 in rhesus and
cynomolgus macaques [38]. However, 1 group of rhesus macaques had only low levels of viral
RNA in the testes and no detectable virus in the prostate or epididymis [44]. In common mar-
mosets, ZIKV RNA in semen was sporadically detected [65].
The female genital tract of macaques was able to sustain ZIKV replication for shorter dura-
tions and with lower viral loads than the male genital tract [33,38,46]. Although cervical and
endometrial cells were susceptible in vitro [35], virus was not detected in the female genital
tract in mice or NHPs for longer than 7 days after infection [33,46]; in 1 study, the ovary sus-
tained higher titres up to 14 days post-infection [35]. Intravaginal infection of mice led to sys-
temic infection [36,40,42,47,48,50,67,68,69] and to adverse congenital outcomes [47]. In
pregnant female mice, sexual transmission led to more ZIKV dissemination to the female
reproductive tract, compared with subcutaneous or intravaginal inoculation [69]. In NHPs the
incubation time following infection was longer for intravaginal infection compared with sub-
cutaneous infection [55].
Table 2. Overview of study designs of included studies.
Category Publications on Zika
virus
Publications on other
flaviviruses
Epidemiological studies
Case reports 44 7
Case series 18 1
Cohort studies 4 —
Case–control studies — —
Outbreak or surveillance reports 1 —
Mathematical modelling studies 2 —
Basic research studies
In vivo studies 35 7
In vitro studies 6 1
Review studies — 2
Total publications 110 18
Reporting on sexual transmission between 2 partners 24a 1
Publications used for quantitative analysis 51 —
Reporting serial interval 12a —
Reporting at least 1 measurement in bodily fluids of interest using reverse transcription PCR or viral
culture
48a —
aOverlap in publications; one publication can report on multiple outcomes (e.g., reporting on serial interval and/or persistence and/or sexual transmission).
https://doi.org/10.1371/journal.pmed.1002611.t002
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In mice, viral titres were lower in the salivary glands than the testes and ovaries [35]. In
NHPs, viral RNA was detected in saliva up to 28–42 days [33,37,38,52,57], and ZIKV could be
cultured at day 7 and day 14 [38,65].
Risk of bias in in vivo studies
Most studies did not describe in detail the methods used to avoid bias. Detailed certainty
assessment of the in vivo studies is provided in S3 Table.
Observational studies
ZIKV transmission between sexual partners. As of 15 April 2018, the US Centers for
Disease Control and Prevention reported that, of 5,672 cases of ZIKV infection in the US, 52
were acquired through sexual transmission [72]. The European Centre for Disease Prevention
and Control reported, as of 13 March 2017, 20 cases of sexual transmission out of 1,737 cases
for which the route of transmission was known [73].
We included 67 reports about ZIKV sexual transmission; measurement of ZIKV infection
status using RT-PCR or viral culture in samples of semen, vaginal fluid, or saliva; or both
[6,20,74–138]. Twenty-four of these studies reported on 36 couples in which a primary partner
with ZIKV infection, who returned from a ZIKV endemic area, is suspected to have transmit-
ted ZIKV to a secondary partner [6,78,79,82,84,85,87,88,90,91,96,100,102,105,113,115,119–
121,123,124,127,131,137] (Table 3). Thirty-four of 36 episodes of transmission were from man
to woman (94%), 1 (3%) was from woman to man [96], and 1 (3%) was from man to man [85].
Penile–vaginal intercourse was reported as the most likely mode of transmission between men
and women, but oral and anal intercourse were mentioned as possible transmission routes in
some reports [6,78,79,84,85,88,90,91,96,100,115]. One study reported transmission of ZIKV
from a vasectomised man to his female sexual partner [115]. Amongst primary infected indi-
viduals, 27/36 (75%) were symptomatic, 2/36 (6%) were asymptomatic, and symptom status
was not reported for the remaining 7/36 (19%).
ZIKV was detected by RT-PCR in blood, urine, saliva, or semen in 14/36 (39%) primary
partners and in 18/36 (50%) secondary partners. No diagnostic method was stated for 29/72
(40%) individuals. In 5/36 (14%) couples, the secondary partner also had a history of travel to
an endemic region [88,91,115,124,137].
Incubation period (element 2) and serial interval (element 3). We were not able to
extract information on the incubation period following sexual exposure to ZIKV, since dates
of exposure of the primary partner and dates of sexual intercourse with the secondary partner
were rarely reported. Thirteen reports about 15 couples reported on dates of symptom onset
for both partners. The median serial interval was 12 days (interquartile range: 10–14.5 days)
[6,78,79,84,85,88,90,96,102,115,124,131,137] and the maximum was 44 days [88].
Duration of infectiousness (element 4). Duration of infectiousness was not measured
directly in any included study. Observational studies measured the duration of detection of
ZIKV in bodily fluids in case reports, case series, and prospective cohort studies. S2 Text pro-
vides additional information.
Case reports and case series. We included 48 publications describing 180 individuals
who underwent diagnostic testing by RT-PCR or viral culture on semen, vaginal fluid, or saliva
at 1 or more time points [75,76,80,81,83–86,88–95,97–100,102–104,107–117,122,124–
126,128–138]. In semen (data available from 37 case reports and case series from 119 individu-
als; Fig 3; S2 Text), the median duration of RT-PCR positivity was 39.6 days (95% CI: 29.9–
49.0 days) and the maximum was 370 days [134]. The median duration based on viral culture
was 9.5 days (95% CI: 1.2–20.3 days) (data from 22 men in 11 reports), with a maximum of 69
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days [115]. The median duration of ZIKV positivity in any fluid from the female genital tract
was 13.9 days (95% CI: 7.2–19.6 days) based on RT-PCR (data from 15 women in 7 reports),
with a maximum of 37 days [133]. The median duration of ZIKV positivity in saliva was 7.3
days (95% CI: 4.2–10.8 days) based on RT-PCR (data from 76 individuals in 23 reports), with a
maximum of 91 days [99]. There were too few data for analysis of viral culture specimens in
female genital tract fluids and saliva.
Prospective cohort studies. One cohort study enrolled 150 women and men with symp-
tomatic ZIKV infection in Puerto Rico. ZIKV was detected by RT-PCR in 31/55 men, with a
median duration of persistence of 34 days (95% CI: 28–41 days). ZIKV RNA was only detected
in saliva or vaginal fluids in a few participants [20]. A second cohort study, amongst people
returning from ZIKV endemic areas or infected in the US, detected ZIKA RNA in the semen
of 60/184 symptomatic men [74]. The mean time to ZIKV RNA clearance was 54 days (95%
CI: 53–55 days). The median duration was not reported, but plotted at approximately 35 days.
Only 3 out of 19 of the semen samples provided within 30 days after symptom onset could be
cultured; none of the 59 samples provided after 30 days could be cultured.
Risk of bias in observational studies. Studies varied widely in risk of bias and complete-
ness of reporting (S3 Table). Many studies reporting on transmission events did not use reli-
able diagnostic methods in both partners, potentially leading to misclassification bias. The
median duration of ZIKV persistence was higher in case reports and case series than in the
prospective cohort study.
Table 3. Key characteristics of the couples (n = 36) for which sexual transmission of ZIKV was suspected.
Characteristic n (%) References
Direction of transmission
Male–female 34 (94%) [6,78,79,82,84,87,88,90,91,100,102,105,113,115,119–121,123,124,127,131,137]
Female–male 1 (3%) [96]
Male–male 1 (3%) [85]
Symptomatic status
Symptomatic 27 (75%) [6,78,79,82,84,85,88,90,96,102,113,115,121,124,127,131,137]
Asymptomatic 2 (6%) [91,100]
Not reported 7 (19%) [87,105,119–121,123]
Secondary infected individual had also travelled to endemic area
Yes 5 (14%) [88,91,115,124,137]
No 31 (86%) [6,78,79,82,84,85,87,90,96,100,102,105,113,119–121,123,127,131]
Serial interval reported
Yes 15 (42%) [6,78,79,84,85,88,90,96,102,115,124,131,137]
No 21 (58%) [82,87,91,100,105,113,119–121,123,127]
Diagnostic certainty for primary infected individual
Confirmed with RT-PCR 14 (39%) [84,85,88,90,91,96,102,115,120,121,124,127,131,137]
Confirmed with serology 4 (11%) [6,78,79,119]
Suspected 3 (8%) [79,100]
Not reported 15 (42%) [82,87,105,113,121,123]
Diagnostic certainty for secondary infected individual
Confirmed with RT-PCR 18 (50%) [79,84,85,88,90,91,96,100,102,115,120,121,124,127,131,137]
Confirmed with serology 4 (11%) [6,78,79,119]
Suspected 0 (0%) —
Not reported 14 (39%) [82,87,105,113,123]
RT-PCR, reverse transcription PCR.
https://doi.org/10.1371/journal.pmed.1002611.t003
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Mathematical modelling studies
Reproduction number (element 5), transmission probability (element 6), and transmis-
sion rate (element 7). We included 2 mathematical modelling studies, both of which used a
deterministic structure [139,140]. Gao et al. used surveillance data from Brazil, Colombia, and
El Salvador [139]; Towers et al. used data from Colombia [140]. Both studies derived the
reproduction number for ZIKV sexual transmission: 0.136 (95% CI: 0.009–0.521) [139] and
“likely below 1” [140]. The 2 studies calculated the proportion of ZIKV infections resulting
from sexual transmission as 3.04% (95% CI: 0.12%–45.73%) [139] and 23% (95% CI: 1%–47%)
[140]. Neither study provides new information about the transmission probability per sex act
or the transmission rate for sexual transmission of ZIKV.
Risk of bias of mathematical modelling studies. For both modelling studies, the data
used to populate the model were not suitable to derive the outcome. The surveillance data on
which these studies based their results did not distinguish between vector-transmitted ZIKV
and sexually transmitted ZIKV. The results of these studies did not provide information about
the size of the risk of sexual transmission. External validation for both models is lacking.
Detailed certainty assessment is shown in S3 Table.
Sexual transmission framework elements. Table 4 summarises findings for the outcomes
of the sexual transmission framework and the GRADE assessment of the certainty of the evi-
dence. S3 Table provides the GRADE evidence profile.
Other flaviviruses
We included 18 studies reporting on the sexual transmission potential of other arthropod-
borne flaviviruses [14,141–157]. Ten of the 18 studies (56%) were in vitro experiments or
observations in animals, and 8 studies (44%) were case reports or case series. JEV was demon-
strated to be transmissible from male to female pigs via semen [141–144]. Persistence of virus
was demonstrated for at least 17 days in boars [141]. JEV can be cultured from the seminal flu-
ids of pigs [145]. In humans, we found 1 case report of male-to-female sexual transmission of
WNV, although the secondary partner also lived in a mosquito endemic area [146]. WNV was
found postmortem in the prostate and testis of a 43-year-old man on immunosuppressive ther-
apy following a kidney transplant [147]. Intravaginal inoculation of WNV in mice led to local
acute inflammation followed by systemic illness in a proportion of the animals [148]. The tes-
tes of 6 Japanese macaques (M. fuscata) showed low DENV neutralising antibody titres [149].
Experimentally DENV-infected pigtail macaques (M. nemestrina) showed dissemination of
virus in the prostate gland and seminal vesicles [150]. DENV RNA could be detected in experi-
mentally infected mice 3 days after infection [151]. In humans, 4 case reports describe the
presence of DENV in saliva, diagnosed by either RT-PCR or viral culture, for up to 7 days
[152–155]. DENV RNA was demonstrated in the vaginal secretion of 1 patient up to 18 days
after onset of symptoms [156]. Female mice that were mated to male mice infected with tick-
Fig 3. ZIKV detection in semen by RT-PCR. The x-axis indicates time in days from symptom onset. The labels on the y-axis represent the date
of publication of the studies, in chronological order, with the last date indicating the date of this analysis. Green lines represent the duration of
RT-PCR positivity in individuals from case reports and case series (n = 119), extending to the last positive RT-PCR measurement. Green dots at
day 0 represent an assumption of RT-PCR positivity for patients with no sample taken at symptom onset. Blue lines represent the interval
between the last positive measurement and the first subsequent negative measure (red dot). The black dotted line represents the publication of
the WHO interim guidelines [2] and the suggested duration of protected sexual intercourse advised in the guidelines (6 months, black triangle).
The black dots and whisker bars represent median aggregated values and 95% confidence intervals for [a] a prospective cohort (n = 55 men) [20]
and [b] the aggregation of all available case reports and case series. Maximum values in these datasets are shown with a red diamond or a red
greater than symbol (for values outside the range of the graph). Lines for which the date is not provided are from the same date as the line above.
RT-PCR, reverse transcription PCR; ZIKV, Zika virus.
https://doi.org/10.1371/journal.pmed.1002611.g003
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borne encephalitis virus had worse reproductive outcomes than ones mated to a group of non-
infected males; in 1 female mouse, the virus was detected [157]. YFV was demonstrated in the
urine and semen of a patient by RT-PCR 21 days after onset of symptoms [14].
Discussion
This systematic review summarises published data related to sexual transmission of ZIKV and
other arthropod-borne flaviviruses published on or before 15 April 2018. In animals, vaginal
and rectal mucosae are susceptible to ZIKV, with the testis as a preferred site of replication.
Male-to-female transmission was more frequent than female-to-male transmission in animal
models and in humans. In humans, we estimated the serial interval for sexually transmitted
infection to be 12 (interquartile range: 10–14.5) days. ZIKV was detectable in semen for a
Table 4. Summary of the evidence on sexual transmission of Zika virus as assessed using the sexual transmission framework.
Element Value Sample
size
References GRADE
1. Susceptibility Summary: based on animal models, rectal and vaginal
mucosae are susceptible to infection. The testes form a
reservoir for virus. Male–female transmission is more
common than female–male transmission.
— [32, 34–36, 40, 43, 47, 49, 51, 58, 59, 63] NA
2. Incubation period
following sexual
transmission
Could not be calculated — NA
3. Serial interval Median: 12 days (interquartile range: 10–14.5) 15
couples
[6, 78, 79, 84, 85, 88, 90, 96, 102, 115, 124, 131, 137] Very
low1
4. Duration of
infectiousness
Male genital tract RT-PCR
(cohorts)
Median: 34 days (95% CI: 28–41) n = 55 [20] Low2
Median: 35 days, mean: 54 days (95% CI: 53–55) n = 184 [74] Low2
Male genital tract RT-PCR
(case reports and case
series)
Median: 39.6 days (95% CI: 29.9–49.0) n = 119 [76,80,84–86,88–
95,97,98,100,102,103,107,109,112,113,115–
117,124,126,128–137]
Very
low2,3
Male genital tract viral
culture
Median: 9.5 days (95% CI: 1.2–20.3) n = 22 [80, 84, 86, 92, 99, 103, 107, 112, 115, 126, 130] Very
low1,2,3
Female genital tract
RT-PCR
Median: 13.9 days (95% CI: 7.2–19.6) n = 15 [95, 104, 108, 110, 111, 114, 133] Very
low1,2,3
Saliva RT-PCR Median: 6.8 days (95% CI: 4.3–9.6) n = 76 [75, 81, 83–85, 89, 90, 92–94, 98, 99, 104, 110, 112, 122,
125, 126, 131, 133, 134, 138]
Very
low1,2,3
5. Reproduction number
due to sexual
transmission
<1 — [139, 140] Very
low4
6. Probability of
transmission per sex act
Could not be calculated — NA
7. Transmission rate (Assumed) — NA
Proportion of cases due to
sexual transmission
3.0% (95% CI: 0.1%–45.7%); 23% (95% CI: 1%–47%) — [139, 140] Very
low4
Estimates of the outcomes and publications that provide evidence for these different elements of the sexual transmission framework are listed by outcome. Additionally,
the certainty assessment using Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology is provided.
1Small sample size or small number of studies.
2Indirect measure of duration of infectiousness.
3Risk of selection bias or selective reporting.
4Serious indirectness and imprecision.
NA, not applicable; RT-PCR, reverse transcription PCR.
https://doi.org/10.1371/journal.pmed.1002611.t004
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median of 34 (95% CI: 28–41) days by RT-PCR and 9.5 (95% CI: 1.2–20.3) days by viral cul-
ture. In mathematical modelling studies, the reproduction number for sexual transmission of
ZIKV was below 1. The overall certainty of the evidence was low. We found no evidence that
other arthropod-borne flaviviruses can be sexually transmitted.
What the study adds to existing research
The ZIKV sexual transmission framework allowed us to synthesise evidence from both animal
and human studies in a structured way, taking into account the risks of bias in the included
studies. Susceptibility of tissues to ZIKV could only be assessed in animal models. There were
consistent findings in animal models that help to explain the overrepresentation of reported
cases of human male-to-female transmission, even though mice are not a natural host for
ZIKV and in vivo studies often use immunocompromised animals [8]. First, vaginal mucosae
are more susceptible than urethral mucosae to infection [36,40,47,49,51,59]. Second, high lev-
els of ZIKV replication in the testes in mice and sustained detection of viral RNA and of virus
in tissue culture in mice and NHP models are consistent with the longer duration of detection
in men than women. Rectal mucosa is also susceptible to ZIKV, so, although only observed
once [85], unprotected anal intercourse is also a likely route of ZIKV transmission. The risk of
bias of the included in vivo studies, as assessed with the SYRCLE tool, was high. Most of these
studies explored the suitability of animal models or investigated pathophysiological pathways,
and potential sources of bias were rarely reported.
Our analysis shows that, when assessed from case reports and case series, the duration of
detection of ZIKV in semen by RT-PCR is overestimated; all reports are of people with ZIKV
detected, and a small number of outliers influence the estimate. A prospective cohort study
that consecutively enrolled people with symptomatic ZIKV infection estimated a shorter dura-
tion of persistence [22]. Case reports and case series are early sources of information about a
new disease, but, by the nature of these studies, researchers report novel and unusual findings.
Parameters and effect sizes estimated from aggregating data from these sources are likely to be
overestimates, reflecting the so-called random high: extreme values in a distribution that are
observed by chance and are more likely to be reported because they are noteworthy [158]. As
evidence has accumulated in well-designed prospective studies, the estimated duration of per-
sistence of ZIKV RNA has decreased. Notably, the prospective cohort study in Puerto Rico
found ZIKV in semen in only half of men with symptomatic infection and vaginal fluid in
only 1 of 50 women. Similarly, ZIKV was found in semen in only 60/183 (33%) ZIKV-infected
men in the US [74]. Persistence of viral RNA in body fluids is often used as a proxy for the
duration of ZIKV infectiousness, although it remains unclear whether the presence of viral
RNA corresponds with infectious virus. ZIKV RNA positivity persists for longer than detec-
tion of ZIKV in viral culture in both mice [47] and human semen samples. However, viral cul-
tures might underestimate the duration of infectiousness if low pH or other specimen-
dependent factors produce false negative results [83,159]. The estimated serial interval was
based on observations from only 15 couples, but was consistent with that of several respiratory
infectious diseases [160]. The serial interval for sexual transmission was towards the lower end
of estimates for mosquito-borne transmission (10–23 days) [161].
Some elements of the infection process, such as the incubation period, transmissibility of
ZIKV per sex act, and transmission rate could not be observed. In the mathematical models
published so far [139,140,162], the estimates were based on assumptions about the transmissi-
bility of mosquito-borne infection. Estimates from our review might provide more reliable
data for use in future modelling studies. The potential for sustained sexual transmission of
ZIKV appears low, based on the reproduction number estimated in the mathematical
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modelling studies. The estimated reproduction number was higher for mosquito-borne trans-
mission, 1.96 (95% CI: 0.45–6.23) than for sexual transmission [139], although this number is
highly dependent on the geographical location [163].
This review did not find evidence supporting sexual transmission of other arthropod-borne
flaviviruses. The continual updating of the literature search identified a finding of YFV in
urine and semen [14]. However, it remains to be clarified for many viruses if detection in
semen means that there is a risk of sexual transmission [13].
Strengths and weaknesses of the study
The strengths of our living systematic review are the high coverage of the body of published lit-
erature, the structured overview, and the reanalysis of individual patient data on persistence of
ZIKV. The automation of search and deduplication processes makes it feasible to keep the
review updated as new information becomes available. Updated analyses of the data from case
reports show regression to the mean of the median estimate of the duration of RNA detection
in semen (https://zika.ispm.unibe.ch/stf/). Future updates of this review will also allow for
incorporation of techniques to synthesise mathematical modelling studies, such as multi-
model ensembles. This study also has limitations. Screening and data extraction were not done
by 2 independent reviewers because of time constraints, but we believe that we reduced errors
by having a second reviewer check the decisions and data extracted. The statistical methods
used to estimate the duration of persistence of ZIKV in bodily fluids assume that all samples
are positive for ZIKV at time 0 [20], which might not be the case. Additionally, the sexual
transmission framework might not include all factors that are required to investigate the risks
of sexual transmission of ZIKV. The certainty of this body of evidence was assessed as being
low or very low because of bias in the observational study designs and the indirectness of evi-
dence from animal studies. The certainty of the evidence base could increase if the design and
reporting of both animal and human studies improve and if their findings are consistent with,
and increase the precision of, the evidence presented here.
Implications and next steps for researchers, clinicians, and policymakers
The risk of sexual transmission of ZIKV is particularly relevant for women who are pregnant
or planning a pregnancy and for people with high levels of sexual partner change such as some
groups of men who have sex with men and women at high risk. An expert group has used the
ZIKV sexual transmission framework to stimulate discussion about research priorities [17].
One important limitation to the generalisability of findings from our review is that the data
that we analysed about sexual transmission of ZIKV in humans relied largely on information
from travellers returning from endemic areas with symptomatic ZIKV infection and their sex-
ual partners. This group probably differs from people in endemic regions in ways that could
affect sexual transmission of ZIKV, such as previous exposure to other flaviviruses [164]. Addi-
tional studies in ZIKV endemic settings could enrol travellers who work in areas with mos-
quito-borne ZIKV transmission and who return to families living nearby but in areas, e.g., at
high altitude, where the vector does not survive [17]. There are unanswered questions about
the potential for asymptomatic ZIKV infection following sexual transmission, since ZIKV
transmitted by mosquitoes often causes asymptomatic infection [165–167], about clinical dif-
ferences between ZIKV infections acquired through sexual and mosquito-borne routes, and
about the long-term consequences of ZIKV in the genital tract, such as its effects on the testes
and on male infertility. Research about the potential for sexual transmission of other flavivi-
ruses is needed, although these viruses often display different symptomatology or affinity for
different species.
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Clinicians and policymakers need information that helps to advise both opposite sex and
same sex couples on how to reduce the risk of sexual transmission of ZIKV. The relationship
between detectable RNA in semen and infectiousness therefore needs to be further investi-
gated in both laboratory and epidemiological studies. Current guidelines for travellers return-
ing from endemic areas advise 6 months of protected intercourse [1,2]. As more information
becomes available, a revision of the duration of protection might be indicated.
Conclusions
This living systematic review gives an up-to-date synthesis of information about the sexual trans-
mission of ZIKV with a structured framework. Planned regular updates will allow timely updating
of relevant data from a rapidly expanding evidence base. We did not quantify the absolute risk of
sexual transmission of ZIKV, but it appears small based on information about the proportion of
people with symptomatic ZIKV who have ZIKV detected in genital secretions and the short
median duration of detection of ZIKV in semen and vaginal fluid. Taking into account all avail-
able data about the duration of detection of ZIKV in culture and from the serial interval, our find-
ings suggest that the infectious period for sexual transmission of ZIKV is shorter than estimates
from the earliest post-outbreak studies, which were based on RT-PCR alone.
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